Bionik Laboratories Corp
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; In… Read more
Bionik Laboratories Corp (BNKL) - Total Liabilities
Latest total liabilities as of March 2023: $5.00 Million USD
Based on the latest financial reports, Bionik Laboratories Corp (BNKL) has total liabilities worth $5.00 Million USD as of March 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bionik Laboratories Corp - Total Liabilities Trend (2011–2023)
This chart illustrates how Bionik Laboratories Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bionik Laboratories Corp Competitors by Total Liabilities
The table below lists competitors of Bionik Laboratories Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alina Holdings PLC
LSE:ALNA
|
UK | GBX787.39K |
|
Brain Scientific Inc
PINK:BRSF
|
USA | $7.43 Million |
|
Metro One Telecommunications Inc
PINK:WOWI
|
USA | $2.74 Million |
|
MITRABAHTERA
BE:MTI
|
Germany | €473.53 Billion |
|
XIANA MINING
MU:DO51
|
Germany | €66.04 Million |
Liability Composition Analysis (2011–2023)
This chart breaks down Bionik Laboratories Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bionik Laboratories Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bionik Laboratories Corp (2011–2023)
The table below shows the annual total liabilities of Bionik Laboratories Corp from 2011 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-03-31 | $5.00 Million | +186.09% |
| 2022-03-31 | $1.75 Million | -68.24% |
| 2021-03-31 | $5.51 Million | +5.87% |
| 2020-03-31 | $5.20 Million | +59.02% |
| 2019-03-31 | $3.27 Million | -59.74% |
| 2018-03-31 | $8.12 Million | +40.57% |
| 2017-03-31 | $5.78 Million | -3.27% |
| 2016-03-31 | $5.97 Million | -4.59% |
| 2015-12-31 | $6.26 Million | +14602.74% |
| 2015-03-31 | $42.58K | +199.18% |
| 2014-03-31 | $14.23K | +762.55% |
| 2013-03-31 | $1.65K | -73.94% |
| 2012-03-31 | $6.33K | +5.53% |
| 2011-03-31 | $6.00K | -- |